Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol Pretreatment in Hyperandrogenic PCOS Patients Undergoing ART
NCT03767569Phase 3Unknown
- Sponsor
- UZ Brussel
- Start
- Sep 2018
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 3, randomised trial (2 arms), sponsored by UZ Brussel. Primary endpoint: Serum testosterone level at 12 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT03767569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03767569.